Section for Anaesthesiology and Intensive Care Medicine, University of Oslo, Rikshospitalet, Oslo, Norway.
Acta Anaesthesiol Scand. 2010 Jan;54(1):16-41. doi: 10.1111/j.1399-6576.2009.02089.x. Epub 2009 Oct 19.
Central neuraxial blocks (CNBs) for surgery and analgesia are an important part of anaesthesia practice in the Nordic countries. More active thromboprophylaxis with potent antihaemostatic drugs has increased the risk of bleeding into the spinal canal. National guidelines for minimizing this risk in patients who benefit from such blocks vary in their recommendations for safe practice.
The Scandinavian Society of Anaesthesiology and Intensive Care Medicine (SSAI) appointed a task force of experts to establish a Nordic consensus on recommendations for best clinical practice in providing effective and safe CNBs in patients with an increased risk of bleeding. We performed a literature search and expert evaluation of evidence for (1) the possible benefits of CNBs on the outcome of anaesthesia and surgery, for (2) risks of spinal bleeding from hereditary and acquired bleeding disorders and antihaemostatic drugs used in surgical patients for thromboprophylaxis, for (3) risk evaluation in published case reports, and for (4) recommendations in published national guidelines. Proposals from the taskforce were available for feedback on the SSAI web-page during the summer of 2008.
Neuraxial blocks can improve comfort and reduce morbidity (strong evidence) and mortality (moderate evidence) after surgical procedures. Haemostatic disorders, antihaemostatic drugs, anatomical abnormalities of the spine and spinal blood vessels, elderly patients, and renal and hepatic impairment are risk factors for spinal bleeding (strong evidence). Published national guidelines are mainly based on experts' opinions (weak evidence). The task force reached a consensus on Nordic guidelines, mainly based on our experts' opinions, but we acknowledge different practices in heparinization during vascular surgery and peri-operative administration of non-steroidal anti-inflammatory drugs during neuraxial blocks.
Experts from the five Nordic countries offer consensus recommendations for safe clinical practice of neuraxial blocks and how to minimize the risks of serious complications from spinal bleeding. A brief version of the recommendations is available on http://www.ssai.info.
中枢神经轴阻滞(CNBs)在手术和镇痛中是麻醉实践的重要组成部分,在北欧国家。更积极的抗血栓形成药物的抗血栓形成药物增加了椎管内出血的风险。受益于这种阻断的患者,最小化这种风险的国家指南在其对安全实践的建议方面存在差异。
斯堪的纳维亚麻醉学和重症监护医学学会(SSAI)任命了一个专家工作组,以建立关于在增加出血风险的患者中提供有效和安全 CNB 的最佳临床实践的北欧共识。我们进行了文献检索,并对(1)CNBs 对麻醉和手术结果的可能益处、(2)遗传性和获得性出血性疾病和用于外科患者抗血栓形成的抗血栓形成药物引起的脊髓出血风险、(3)发表的病例报告中的风险评估和(4)发表的国家指南中的建议进行了专家评估。工作组的建议可在 2008 年夏天在 SSAI 网页上进行反馈。
神经轴阻滞可以改善舒适度并降低手术后发病率(强证据)和死亡率(中度证据)。止血障碍、抗血栓形成药物、脊柱和血管的解剖异常、老年患者以及肾功能和肝功能不全是脊髓出血的危险因素(强证据)。发表的国家指南主要基于专家意见(弱证据)。工作组就北欧指南达成共识,主要基于我们专家的意见,但我们承认在血管手术期间的肝素化和在神经轴阻滞期间围手术期使用非甾体抗炎药方面存在不同的做法。
来自五个北欧国家的专家提供了关于安全的临床实践的共识建议神经轴阻滞以及如何最小化严重并发症的风险来自脊髓出血。建议的简短版本可在 http://www.ssai.info 上获得。